BioSpecifics Technologies Corp.

2024-08-22

Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - BioSpecifics Technologies Corp.. Produces and licenses collagenase used as a topical treatment of dermal ulcers such as bedsores and burns.

Produces and licenses collagenase used as a topical treatment of dermal ulcers such as bedsores and burns. Includes explanation of therapy, investor data and profile of company based in Lynbrook, New York. (Nasdaq: BSTC)

BioSpecifics Technologies Corp.